TY - CONF T1 - In vitro effects of vandetanib on VEGFR2, EGFR and RET phosphorylation, endothelial cell tube formation, and tumor cell growth and survival JO - MOLECULAR CANCER THERAPEUTICS PY - 2007/01/01 AU - Brave SR AU - Marshall G AU - Wainwright A AU - James N AU - Acheson N AU - Howard Z AU - Ratcliffe K AU - Speake G AU - Barry ST AU - Hickinson DM AU - Ryan AJ ED - VL - 6 IS - 12 SP - 3589S EP - 3589S Y2 - 2024/10/23 ER -